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Helix alignment and dynamicsibians are a rich source of antimicrobial peptides. The two antimicrobial peptides
PGLa and magainin 2, isolated from the African frog Xenopus laevis, have been shown to act synergistically by
permeabilizing the membranes of microorganisms. In this report, the literature on PGLa is extensively
reviewed, with special focus on its synergistically enhanced activity in the presence of magainin 2. Our recent
solid state 2H NMR studies of the orientation of PGLa in lipid membranes alone and in the presence of
magainin 2 are described in detail, and some new data from 3,3,3-2H3-L-alanine labeled PGLa are included in
the analysis.
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Antimicrobial peptides (AMPs) are universally present in all
organisms ranging from bacteria and plants to insects, amphibian
and mammals. They are now widely accepted as an important part of
the innate immune systemof higher organisms [1–4]. AMPs have been
proposed as a potential source of new antibiotics, which are needed to
ﬁght increasingly common multiresistant pathogens. Many AMPs
interact speciﬁcally with lipid membranes, and they do not seem to
induce resistance in bacteria. In this report, we review the literature
on PGLa, one of the ﬁrst AMPs found in amphibians, and its synergistic
effects with magainin 2, a closely related peptide found in the same
frog skin. Our special focus will be on solid-state NMR (SSNMR)
studies, which have been used to investigate these peptides in a lipid
environment and to determine their orientations relative to the lipid
bilayer [5–17]. These studies have reported that PGLa and magainin 2
form stable pores in membranes as heterodimeric complexes [12].
Some new SSNMR data will be presented here and included in a more
detailed structure analysis.
1.1. PGLa and other antimicrobial peptides from Xenopus laevis
The African clawed frog X. laevis is the origin of several AMPs,
which are listed in Table 1. The antimicrobial peptide PGLa was found
in the skin of X. laevis during a search for caerulein precursors in frog
skin secretions [18,19]. The study was motivated by an interest in the
biosynthesis of caerulein, a dodecapeptide that is homologous to
mammalian hormones. Using total mRNA from the skin of X. laevis, a
cDNA library was constructed and screened with a complementary
part of the mRNA of caerulein. Apart from several caerulein
precursors, also the precursor for a novel peptide was found. This
peptide of 25 amino acids would contain a COOH-terminal glycine
which has been found to be a signal for the formation of a C-terminal
amide [20,21], and a 24 amino acid peptide with an amidated C-
terminus was therefore predicted, and was called PYLa (Peptide
from tYrosine to Leucine amide) [18]. This peptide was not found in
the frog skin, but a shorter one, PGLa (Peptide from Glycine to Leucine
amide), corresponding to PYLa (4–24), was isolated and sequenced
[22,23].
After the initial discovery of bioactive peptides in the frog skin, all
peptides secreted by X. laevis were screened systematically using fast
atom bombardment mass spectrometry (FAB-MS) and HPLC. Over 30Table 1
Magainin family peptide sequences.
Name Full name One-letter coded peptide sequence
CPF 1a Caerulein precursor fragment 1 GFASFLGKAL KAALKIGANA LGGAPQQ
LPF Levitide precursor fragment GWASKIGQTL GKIAKVGLQG LMQPK
MAG1 Magainin 1 GIGKFLHSAG KFGKAFVGEI MKS
MAG2 Magainin 2 GIGKFLHSAK KFGKAFVGEI MNS
PGLa Peptide from G to L amide GMASKAGAIA GKIAKVALKA L-NH2
PGQ Peptide from G to Q GVLSNVIGYL KKLGTGALNA VLKQ
PYLa Peptide from Y to L amide YVRGMASKAG AIAGKIAKVA LKAL-NH2
XPF Xenopsin precursor fragment GWASKIGQTL GKIAKVGLKE LIQPK
Designer
analogues
MSI-78 GIGKFLKKAK KFGKAFVKIL KK-NH2
MSI-103 (KIAGKIA)3-NH2
a Another 10 CPF peptides with almost identical sequences are listed in [126].different peptides were found, including PGLa, xenopsin precursor
fragment (XPF), caerulein precursor fragment (CPF), and thyrotropin-
releasing hormone (TRH) [24–27], as well as multiple inactive
proteolytic fragments due to the simultaneous presence of an
endopeptidase, the magaininase, which is probably released as a
detoxiﬁcation means [28]. Two nearly identical peptides were shown
to have antimicrobial properties and were called magainin 1 (MAG1)
and magainin 2 (MAG2) (from the Hebrew word magain, meaning
shield) [29]. These were independently characterized by another
group and called PGS (Peptide from Glycine to Serine) and PGS[Gly-
10;Lys-22] [30]. Soon, it was shown that PGLa and XPF also exhibited
antimicrobial properties comparable to the magainins [31].
It was noted that the precursors of many of these frog peptides had
striking sequence similarity, for example the precursors for proma-
gainin, procaeruleins, proxenopsin, and PGLa, all have a conserved 19
residue signal peptide. It was proposed that the genes for the four
kinds of peptides were derived from a common ancestral gene [30,32].
Later also the peptide levitide was added to the list [33]. It was thus
obvious to classify them as all belonging to the same “magainin
family” of peptides, and several of them have been shown to have
antimicrobial activity, including MAG1, MAG2, PGLa, several different
CPFs, XPF, and peptides called LPF and PGQ [34]. The sequences of
these peptides are given in Table 1. Notably, of all the magainin family
peptides, PGLa is the only one with an amidated C-terminus.
Apart from the skin, these peptides have also been found in other
parts of X. laevis; in the stomach [35], in “granular multinucleated
cells” within the gastric mucosa [36], in granular glands [37], and in
granule-laden eosinophilic intestinal cells [38]. The latter cells were
proposed to be analogues of the mammalian Paneth cells, which
secrete antimicrobial defensin peptides in humans [39,40]. Peptides
similar to PGLa and MAG2 are also found in mammals [41,42].
1.2. Biological functions of magainin family peptides
Many AMPs have been screened for other biological functions
apart from killing bacteria, and it has been reported that PGLa and
MAG2 also show anticancer, antiviral and antifungal activity. PGLa can
inhibit the growth of tumor cells [43], and similar effects have also
been observed for MAG2 and analogues [43–48]. (For a recent review
on anticancer activities of AMPs in general, see [49].) This antitumour
effect is found at peptide concentrations lower than the cytotoxic
concentration in normal cells, and the selectivity for cancer cells may
be due to a perturbed membrane composition (vide infra), as tumor
cells have an increased amount of negatively charged lipids on their
surface compared to normal cells [50].
More recently, the fungicidal activity of magainins and PGLa has
been investigated. Magainins and PGLa are active against Candida
albicans [51]. PGLa was also shown to be active against amphotericin
B-resistant C. albicans, Candida krusei, Aspergillus fumigatus strains,
and a ﬂuconazole-resistant Candida glabrata isolate [52]. MAG1,
MAG2, PGLa, CPF, ranalexin, and dermaseptin were shown to kill or
inhibit the growth of Batrachochytrium dendrobatidis and Basidiobolus
ranarum, two types of fungi attacking frogs, but they were found to be
ineffective against Acromonas hydrophila, a bacterium able to infect
frogs [53]. The fungus C. glabratawas on the other hand insensitive to
PGLa and MAG2, indicating that this species is able to withstand the
activities of cationic antifungal peptides [54].
The antiviral activity of MAG1, MAG2, and PGLa was studied
against two types of viruses [55]. PGLa and MAG2, but not MAG1,
markedly reduced the infectivity of channel catﬁsh virus in vitro,
1669E. Strandberg et al. / Biochimica et Biophysica Acta 1788 (2009) 1667–1679while frog virus 3 was two- to four-fold less sensitive to these
peptides. These peptides act rapidly and over a wide rang of
physiologically relevant temperatures to reduce virus infectivity.
These results extended previous ﬁndings and strongly suggest that
various amphibian and piscine AMPs may play important roles in
protecting ﬁsh and amphibians from pathogenic viruses [55].
Once it had been discovered that magainin and PGLa show
antimicrobial activity, several groups started structure activity studies
to search for more effective analogues [34,56,57]. One notable
example of such PGLa analogue with higher antimicrobial activity
than the parent peptide is the designer peptide MSI-103, which has
two positive charges more than PGLa and is based on a heptameric
segment of PGLa [34,58–60].
1.3. Mechanism of action
PGLa and MAG2 amide were shown to dissipate the electric
potential across mitochondrial membranes and the dependence of
this effect on the concentration of added peptide suggested that they
act in a coordinated manner, and are probably active as multimers.
This model is consistent with the formation of a channel across the
inner mitochondrial membrane. It was shown that these channels
allow the passage of sucrose [61–63]. It was thus proposed that these
peptides kill bacteria by speciﬁcally destroying or permeabilizing
prokaryotic membranes, whereas eukaryotic cells are not affected.
The membrane selectivity of these cationic AMPs is at least partly
due to their strong electrostatic interaction with negatively charged
lipids, which are abundant in bacterial membranes but not in
eukaryotic plasma membranes. One study found that the binding
constant of PGLa to negatively charged phosphatidylcholine (PC)/
phosphatidylglycerol (PG) (3:1) vesicles is a factor of 50 larger than
for neutral PC vesicles. The negatively charged membrane accumu-
lates the cationic peptide at the lipid–water interface, thus facilitating
further insertion into the membrane [64]. The same study also found
that an important contribution to the binding of PGLa is the
membrane-induced structural transition from random coil to an
amphipathic α-helix. The peptide is unstructured in solution but
adopts an α-helical conformation when bound to the membrane.
Helix formation is an exothermic process, contributing approximately
70% to the binding enthalpy and 30% to the free energy of binding. A
slower endothermic process was also detected at peptide-to-lipid
molar ratios (P/L) above 1:60 and was correlated with the induction
of membrane leakage. This process was attributed to lipid perturba-
tion and/or peptide pore formation [64].
A direct study of the activity of PGLa on Escherichia coli cells was
performed by atomic force microscopy imaging of whole cells under
physiological conditions [65,66]. The topography of the cells and their
stiffness were monitored by atomic force microscopy before and after
the addition of peptides giving a 10 μM ﬁnal peptide concentration.
The peptide ﬁrst reduced the stiffness of the cell surface leading to a
loss of topographic features, and led to the formation of micelles,
probably after disruption of the outer membrane. At this stage, the
bacterial pili were also seen to have disappeared. In a second stage
further damage led to total cell rupture. Interestingly, the addition of
Mg2+ ions partially inhibited the effects of PGLa, suggesting that PGLa
can interact with the outer membrane and displace Mg2+ from
lipopolysaccharides (LPS), by inserting itself into the bilayer and
cross-bridging the negative charges of LPS lipids [65].
Apart from these clear indications that PGLa and magainin kill
bacteria by disrupting their membranes, further studies of their effects
on model membrane have been performed, which showed speciﬁc
interactions between PGLa and PG in monolayers at the air/water
interface [67], and signs that PGLa can penetrate into the hydrophobic
core of membranes [68]. In a recent small angle scattering X-ray
(SAXS) study in gel phase lipids, the peptide–lipid interactions were
found to depend not only on the lipid head group (PC or PG) but alsoon the acyl chains [69]. In a study of PGLa in PG lipid systems, using
DSC, X-ray scattering, and 2H NMR on deuterated lipids, different
behavior was found in gel phase and liquid crystalline phase lipids
[70]. In the gel phase, PGLa induced a quasi-interdigitated phase,
which is most pronounced for C18-PG. In the ﬂuid phase an increase
of the membrane thickness and NMR order parameter was found
for C14- and C16-PG bilayers, though not for C18-PG. The peptide was
not directly observed in these studies, but the results could be
explained by a transmembrane orientation of PGLa, with a perfect
hydrophobic match between the thick C18 bilayer core and the
peptide length, while the shorter lipids stretch to accommodate the
peptide [70].
2. Synergistic effects of PGLa and magainin 2
Soon after the antimicrobial effect of MAG2 and PGLa had been
observed, it was found that a mixture of the two peptides showed
higher membrane perturbing and antimicrobial effects than either
peptide alone. As both peptides are present simultaneously in the
same tissue, the antimicrobial activity of frog skin is greatly enhanced
by this synergy, which highlights the important role of this biological
strategy.
This synergistic enhancement was ﬁrst noted in studies of
membrane potential, which is decreased by MAG2 amide, magainin
A (an analog of MAG2) and PGLa on their own and in combinations
[71]. It was also shown that PGLa mixed with a small non-perturbing
amount of MAG2 amide is more than 20 times more potent than PGLa
alone at inducing the release of carboxyﬂuorescein from liposomes
[72]. Synergismwas also demonstrated in terms of the induced release
of respiratory control and reduction in motility of hamster sperma-
tozoa [73], membrane permeabilization [74], liposome permeabiliza-
tion, toxic effects on tumour cells, membrane potential dissipation,
and antimicrobial activity [43].
The occurrence of synergy in all these different assays suggested
synergy in the primary activity of the peptides, namely the
permeabilization of membranes, probably through the formation of
pores with a multimeric mixed composition of transmembrane
peptides [43]. It was reported that mixtures of PGLa and MAG2 have
amaximummembrane permeabilization at a 1:1 molar ratio, and that
the two peptides must form a stoichiometric 1:1 complex in the
membrane [75]. This study also showed by ﬂuorescence and dye
release assays that the putative heterodimers as well as each
component peptide can form pores. The rate of pore formation
follows the order complex≥PGLaNMAG2, whereas the pore lifetime is
in the order MAG2NcomplexNPGLa. Therefore, the synergism is a
consequence of the formation of a potent heteromolecular complex,
characterized by fast pore formation and moderate pore stability [75].
An enhanced pore formation activity of a PGLa/MAG2 mixture was
also suggested from isothermal titration calorimetry and dye release
experiments [64].
The 1:1 stoichiometry of the PGLa/MAG2 complex indicates that
heterodimers form, and there are other studies supporting this
hypothesis. Several studies show that MAG2 forms oligomers in lipid
bilayers. The sigmoidal binding isotherms found for MAG2 binding to
PG vesicles could be explained by the formation of dimers or trimers
[76]. In a ﬂuorescence study, MAG2 analogues were found to form
antiparallel dimers in PG vesicles [75], and the MAG2 dimers were
directly observed using TRNOE NMR experiments of peptides loosely
bound to DLPC vesicles [77]. An antiparallel dimer of helical peptides
was calculated, and the formation of parallel trimers or antiparallel
tetramers could be excluded, based on intermolecular NOE con-
straints [77]. MAG2 was found by solution state NMR to form a bent
helix in a monomeric form in micelles [78], so the dimerization of
MAG2 seems to occur only in membranes. However, an antiparallel
dimer was observed for the magainin analogue MSI-78 (also known
as pexiganan) in micelles [79]. It is thus clear that magainin family
Fig. 1. Deﬁnitions of the orientational angles. (A) The tilt angle (τ) is the angle between the membrane normal and the helix long axis, which is deﬁned to point from the N- to the C-
terminus. (B) The azimuthal rotation angle (ρ) is deﬁned as a right-handed rotation around the helix long axis, with 0° deﬁned to place the vector from the helix axis to the Cα atom of
position 12 (marked with a white circle) parallel to the membrane plane.
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for their activity, since disulﬁde-linked MAG2 dimers showed
enhanced permeabilization and antimicrobial activity, compared to
the monomeric peptides [80,81]. Synthetic dimers of alamethicin
with a linker between two monomers also form channels with
conductances similar to those measured for the non-linked form of
the peptide, and in some cases with much longer pore life-times [82].
Heterodimers of AMPs have also been observed; there is a known
AMP from the tree-frog Phyllomedusa distincta, distinctin, in
which two different polypeptide chains are connected by a disulﬁde
bridge [83].
It is thus not surprising that PGLa/MAG2 heterodimers can form
and can be more active than either peptide alone. To detect the
putative heterodimer, analogues of MAG2 and PGLawith a Cys residue
at either terminus were synthesized [84]. Cross-linking experiments
suggested that PGLa and MAG2 form a parallel heterodimer in PC/PG
membranes, but not in solution. The isolated parallel heterodimers
had a much higher membrane permeabilization activity compared to
either peptide alone, indicating that the observed functional syner-
gism can be explained by heterodimer formation [84]. In a further
study of the cross-linked heterodimer, it was found that the disruptive
effects against erythrocytes and PC bilayers were also enhanced. It
might therefore be advantageous for an organism to produce the two
partner peptides separately, rather than as a covalently linked dimer,
to avoid negative side-effects and increase the selectivity against
microorganisms [85].
Synergism has also been studied for other systems involving PGLa.
Combinations of the common antifungal compound amphotericin B
and PGLa showed synergism against four of seven tested bacterialFig. 2. Helical wheel representations of PGLa and MAG2. Charged residues and terminal charg
PGLa that have been selectively labeled with Ala-d3 for NMR observations are marked by cistrains. The growth inhibitory activity of amphotericin B was
enhanced by concentrations of PGLa below MIC, without affecting
its hemolytic activity, suggesting that PGLa and other studied peptides
may be suitable candidates for combination therapy [86]. In contrast,
ﬁve different designed tryptophan-rich AMPs did not show any
synergy when combined with PGLa [87], nor did silver in the form of
nanoparticles or in ionic solution [88].
3. Solid-state NMR studies of antimicrobial peptides
3.1. Solid-state NMR methods
Solid-state NMR is practically the only method available to study
the detailed structure and dynamics of membrane-active peptides in
their native lipid environment, and has been used to characterize the
behavior of several AMPs, among them PGLa and MAG2, in lipid
bilayers [5,8–12, 89–93]. The main strategy is to calculate the
molecular orientation in the membrane from anisotropic nuclear
spin interactions, like chemical shift anisotropy, dipolar couplings or
quadrupolar couplings of isotope labels that have been selectively
introduced at speciﬁc positions in the peptide. From themeasurement
of such interactions, it is possible to determine the orientation of the
labeled reporter groups in the molecule with respect to the external
magnetic ﬁeld of the NMR spectrometer. By preferentially using
macroscopically oriented membrane samples, several such orienta-
tional constraints can give the orientation of the peptide relative to the
membrane normal with high accuracy [93]. The orientation of the
peptide is conveniently deﬁned by the tilt angle, τ, and the azimuthal
rotation angle, ρ, deﬁned in Fig. 1.es are indicated. The hydrophobic sectors of the peptides are shown in grey. Residues of
rcles.
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structural model of the peptide exists, and that the orientations of the
reporter groups are ﬁxed within this 3D molecular framework. The
secondary structure of PGLa has been studied with several different
methods. Circular dichroism (CD) showed that PGLa has no folded
structure in aqueous buffers or in the presence of PC vesicles, but in
the presence of negatively charged vesicles it assumed an α-helical
conformation [68,94]. The same result was obtained by Fourier
transform infrared spectroscopy (FTIR) [95]. The explanation is that
the cationic peptide binds to a negatively charged membrane as an
amphipathicα-helix, but that it does not bind to uncharged vesicles at
the low concentrations used in the CD and FTIR experiments. When
bound to dodecylphosphocholine (DPC) micelles, PGLa was shown by
solution-state 1H NMR to form an α-helix between positions 6 and 20
[96]. MAG2 was also shown by CD to form an amphipathic α-helix in
membranes [97], and NMR experiments showed MAG2 to form an α-
helix in sodium dodecyl sulfate or DPC micelles [98,99]. Both peptides
were thus modeled as regularα-helices in the analysis of SSNMR data.
The helical wheel representations of the two peptides are shown in
Fig. 2.
For the SSNMRexperiments, selective isotope labels are placed into
rigid positions of the molecular framework to get local information
about the orientation of these speciﬁc positions in the peptide. There
are several different labeling schemes, using different spin interac-
tions, and giving slightly different information. The isotopes that have
so far been used for PGLa are 15N, 19F and 2H.
3.2. 15N NMR studies
By labeling the amide nitrogen of any amino acid with 15N, it is
possible to perform SSNMR studies without disturbing the peptide
structure. The chemical shift of the amide 15N nucleus in an α-helical
peptide will give direct information about the tilt angle of the peptide
relative to the bilayer normal. From a single label it can be estimated
whether the peptide is bound to the membrane surface, in the so-
called S-state, or whether it is inserted in a transmembrane
orientation, the so-called I-state. It is however not possible to get an
exact tilt angle from a single 15N-label, and the azimuthal angle
remains completely undeﬁned [93]. However, by labeling several
positions individually, and by doing two-dimensional NMR experi-
ments such as polarization inversion spin exchange at themagic angle
(PISEMA), the full orientational information can be obtained [100–
103], and even dynamic aspects can be described [104].
3.3. 19F NMR studies
Fluorine is a highly sensitive NMR nucleus, 10–100 times more
sensitive than conventional SSNMR isotope labels, and there is no
natural abundance background [89,92,105]. The advantages of 19F
NMR studies on AMPs are that less material can be used, or
alternatively less NMR time is needed, and lower peptide-to-lipid
ratios can be studied, down to P/L=1:3000 [106]. For peptides
labeled with a single 19F, the chemical shift gives orientational
information. However, for practical reasons it has been found more
useful to label peptides with CF3-groups and use the homonuclear
dipolar couplings between the 19F nuclei in the rotationally averaged
CF3-group as orientational constraints. [For details see our recent
reviews [89,92,93] and references therein.] So far, 4-CF3-phenylgly-
cine (CF3-Phg) and CF3-bicyclopentylglycine (CF3-Bpg) have been
used to study PGLa and other membrane-active peptides [8–
10,59,91,107–109]. In this 19F NMR approach, a single labeled position
cannot yield the peptide orientation, but by using four or more
individual labels an accurate determination of both tilt and azimuthal
angles is usually possible [89,92,93]. A potential problem is that the
introduction of non-natural 19F-labeled amino acids might disturb the
peptide structure and orientation. Therefore the activity of peptidemutants should be tested, and only those retaining the full biological
activity should be used in the SSNMR experiments.
3.4. 2H NMR studies
When peptides are labeled with 2H, the quadrupolar coupling
between the quadrupolar moment of the nucleus and the electric ﬁeld
gradient is used as an orientation-dependent NMR parameter [93].
Most suitable are Ala-d3 labels, where the methyl group is deuterated,
as in this case the orientation of the Cα–Cβ bond with respect to the
magnetic ﬁeld can be determined from the measured quadrupolar
splitting [5,11,12,110,111]. As for 19F-labels, at least four data points
obtained from four individually Ala-d3 labeled peptides are needed to
determine the peptide orientation. Both the tilt and the azimuthal
angles can be determined with high accuracy, and if native Ala
positions in the peptide sequence are labeled with Ala-d3, no
disturbance is introduced. From 8 labeled positions in a helix, it has
even been possible to obtain a detailed picture of the whole-body
motions of the peptide in the membrane [90].
3.5. Experimental details
In this paper, a comprehensive analysis will be presented for 2H
NMR data on Ala-d3 labeled PGLa. Previously, 8 different positions
have been labeled with Ala-d3, and here three additional labels will be
added to the analysis, using new measurements to complement the
previously published data. Some general information about the new
experiments is given here, but for more details the reader should
consult the references cited below.
Peptides were synthesized using standard Fmoc solid-phase
peptide synthesis protocols [112]. Ala-d3 was introduced to replace a
single residue at the position of Val-16, Ala-17, or Ala-20 in PGLa as
previously described for other labeled positions Ala-6, Gly-7, Ala-8,
Ile-9, Ala-10, Gly-11, Ile-13, and Ala-14 [5,109].
Macroscopically oriented NMR samples with PGLa/DMPC (molar
ratio 1:50) and PGLa/MAG2/DMPC/DMPG (1:1:75:25) were pre-
pared, inwhich the lipid bilayers containing the reconstituted peptides
were oriented on thin glass plates [5]. In short, peptides and lipidswere
co-dissolved in organic solvents and spread onto the glass plates. After
complete evaporation of the organic solvents, the ﬁlmwas hydrated in
a hydration chamber at 48 °C at 96% humidity using deuterium-
depleted water. The stacked glass plates were wrapped in paraﬁlm
for the NMR measurements. In addition, unoriented multilamellar
samples were prepared with PGLa/DMPC (1:200) by co-dissolving
lipids and peptides, followed by vacuumdrying to a ﬁlm and hydrating
the dry peptide-lipid ﬁlm to a ﬁnal hydration of 50% (w/w).
2H NMR spectra were acquired on a 500 MHz or 600 MHz Avance
spectrometer from Bruker Biospin (Karlsruhe, Germany), using a
standard solid-echo pulse sequence [5]. The orientation of the lipid
bilayers was checked by 31P NMR on the phospholipids head groups
[5].
For calculating the orientation of the peptides in the lipid bilayer, a
regular α-helical conformation was assumed, as previously veriﬁed.
From the 2H NMR data analysis, the tilt angle, τ, and the azimuthal
rotation angle, ρ, were determined (see Fig. 1) [5]. Additionally, an
order parameter Smol in the range between 0.0 and 1.0 was used to
account for non-speciﬁc dynamics of the peptide. This has the effect of
scaling the calculated splittings, as Smol=1 corresponds to a static
peptide with no motion, whereas Smol=0 corresponds to isotropic
motion where the quadrupolar splitting is fully averaged to 0.
The quadrupolar splitting is given by
Δmq = 42kHz×Smol× 3 cos2 θ−1
  ð1Þ
where θ is the angle between the C–CD3 bond and the magnetic ﬁeld,
which in turn depends on the τ and ρ angles [111]. It can be noted that
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experimental spectrum, and therefore absolute values are used in the
ﬁt. However, if the absolute value of the splitting is larger than
42 kHz×Smol, then it is seen from Eq. (1) that the splitting must be
positive, and this information is included in the ﬁtting procedure.
4. Solid-state NMR on magainin 2 and PGLa
4.1. Solid-state NMR on magainin 2 (alone)
The sequence of MAG2 is provided in Table 1, and the helical
wheel in Fig. 2. The ﬁrst SSNMR studies of MAG2 were performed
with a single 15N-label, and from the chemical shift of this label it
was determined that the peptide is oriented ﬂat on the surface of
bilayers composed of POPC, POPC/POPG, POPE/POPG, and POPC/
POPG/cholesterol [6,7,13]. In one study, 8 positions were speciﬁcally
labeled with 15N, and chemical shifts were measured on MAG2 in
POPE/POPG bilayers. All positions gave similar chemical shifts [14].
For 4 of the labeled positions, also 1H–15N dipolar couplings were
measured, and an analysis of all the data showed the peptide to be
oriented with the helix axis perpendicular to the magnetic ﬁeld, in
the S-state. No values of τ and ρ were given [14]. In a more detailed
study, not only the chemical shift but also the whole CSA tensor and
the 15N–1H dipolar coupling were measured on Gly-18 15N-labeled
MAG2, in dry peptide powder, and in hydrated unoriented and
oriented POPC/POPG bilayers [113]. The CSA tensor was different in
the hydrated lipid sample than in dry powder, and it was concluded
that the CSA tensor used to analyze NMR data should be determined
in the sample of interest to avoid errors. The CSA values indicated
that the peptide forms an α-helix in lipid bilayers but not in the dry
powder. The chemical shift of the oriented sample was consistent
with those found previously and indicated an S-state [113]. In most
of these studies, a single P/L of 1:33 was used. For a magainin
analogue, the designer-made peptide MSI-78 (see Table 1), a 15N
NMR experiment on a single label also showed an S-state in POPC at
P/L=1:33 [114].
A REDOR study was performed on a 13C- and 15N-labeled MAG2
analogue, E19A-MAG2 amide [115], to measure the distance between
these two labels and thereby determine the local secondary structure.
As the experiment was done in frozen DPPG or DPPC/DPPG lipids, the
result may not be fully applicable to peptides in membranes at high
temperature where the lipids are in a liquid crystalline phase. At high
concentration there was some evidence of two populations of
peptides: one population formed α-helices and the other formed β-
strands. From the distances determined between 13C-labels in the
peptide and the 31P nuclei in the lipid head groups, the study
concluded that the MAG2 analogue resides ﬂat on the membrane
surface.
MAG2 is one of the best known AMPs and has sometimes been
used as a test molecule for new SSNMR experiments, such as 2D and
3D experiments on speciﬁcally and uniformly 15N-labeled peptides
[15–17]. A PISEMA experiment on fully 15N-labeled MAG2 in POPC/
POPG (4:1) showed a crowded spectrum, where the positions of the
peaks were again indicative of an S-state. By extending the experi-
ment into a third dimension, individual peaks could be resolved, and a
more detailed structure and orientation could be determined [16,17].
Both tilt and rotation angles were determined, but no exact values
were given. The tilt was close to 90°, and the charged amino acids
were all on the peptide face pointing towards the water, as expected
for this amphipathic helix.
All these SSNMR studies showed MAG2 in a surface-bound
orientation. It can be noted that oriented circular dichroism (OCD)
and diffraction studies have shown that in POPC bilayers MAG2
was always in an S-state, independent of peptide concentration up to
P/L=1:20 [116]. However, a concentration dependent re-alignment
of MAG2 was observed in DMPC and DMPC/DMPG bilayers [116–119].No SSNMR studies of MAG2 in these lipid systems have so far been
published.
In a Monte Carlo simulation, the free energy of transfer of amino
acid side chains between regions of different hydrophobicity was used
to estimate the orientation and depth of insertion of α-helical
peptides in a lipid bilayer, among them MAG2 and PGLa [120]. In
this study, both PGLa and MAG2 were suggested to occur preferen-
tially in the S-state.
4.2. Solid-state NMR on PGLa (alone)
The sequence of PGLa is shown in Table 1 and the helical wheel in
Fig. 2. PGLa was shown to form an α-helix between residues 6 and 20
when associated with DPCmicelles by solution-state NMR [96], which
is consistent with previous CD results [68]. SSNMR experiments were
performed on six selectively 15N-labeled peptides in oriented POPE/
POPG (3:1) samples at P/L=1:43 [96]. The 15N chemical shifts of each
of the different labeled positions showed that the peptide has a
surface orientation with a tilt of about 90°, while the rotation angle
was not determined. 15N-SSNMR on non-oriented samples demon-
strated that the N-terminal residues are highly mobile and that the
mobility decreases towards the C-terminus. In a later 15N NMR study,
Gly-11 was 15N-labeled [10], and in DMPC bilayers a change in the
chemical shift between P/L=1:200 and 1:50 indicated a concentra-
tion dependent re-orientation of the peptide. Using only a single
labeled position, the tilt angle could only be estimated from the 15N
NMR data, but this result is consistent with more accurate tilt angle
determinations using 19F and 2H NMR (see below).
PGLa was one of the ﬁrst AMP studied by 19F SSNMR, and initially
4F-Phg was used as a 19F-label, to calculate the peptide orientation
from the chemical shift. These labeled PGLa analogs were examined
at different concentrations in DMPC bilayers and showed that sig-
nals could be detected even at very low peptide concentrations down
to P/L=1:3000 [106]. At P/L=1:100 in DMPC/DMPG, the chemical
shift of different labeled positions was found to change but was in-
dependent of the PC/PG ratio. These observations indicated two
different, well-deﬁned orientations of PGLa in the membrane at high
and low peptide concentration, but the tilt and azimuthal angles could
not be determined due to lack of information about the tensor
orientation and torsion angle dynamics of the 4F-Phg side chain [109].
These problems were overcome by using CF3-Phg as a label, since
in this case the homonuclear dipolar couplings were used as an
orientation dependent parameter, and the tensor for this interaction is
well known; moreover, due to fast rotation of the CF3-group, the
torsion angle dynamics is averaged out [94]. Using this label in
DMPC at P/L=1:200, the orientation of PGLa could be determined
from 19F-labels at four speciﬁc positions. It was found that the helical
peptide lies ﬂat on the membrane surfacewith a tilt angle close to 90°,
and with the charged residues pointing towards the aqueous phase
[94]. Biological tests were performed to investigate the effect of
introducing the non-natural 19F-labeled amino acids in the sequence
of PGLa. Only those positions where the labeling did not show any
change in the biological activity nor in the CD spectrum were used in
the NMR analysis [94,109]. In general, it was found that hydrophobic
residues like Val, Ile and Leu could be readily replaced by CF3-Phg
without disturbing the peptide structure and function.
In a further study, PGLa labeled with CF3-Phg was incorporated
into DMPC at P/L=1:200 and 1:50, and it was found that the helix
orientation changed with peptide concentration [10]. At the higher
P/L a new orientational state was found, with peptides tilted about
125°; this was called the T-state (or tilted state), being the ﬁrst
time that such a state was observed for AMPs. These result from
PGLa labeled with CF3-Phg were later corroborated in experiments
where CF3-Bpg was used as an improved 19F-label, that has (unlike
CF3-Phg) no tendency to racemize during solid-phase peptide
synthesis [9,121].
Table 2
Quadrupolar splittings in kHz from Ala-d3 labels substituted in PGLa at different
positions, and in different lipid systems.
Labeled peptide PGLa/DMPC 1:200a PGLa/DMPC 1:50 PGLa/MAG2/DMPC/
DMPG 1:1:75:25
PGLa-A6 15.6b 18.2b 33.6c
PGLa-G7 9.6b 2.5b 3.0c
PGLa-A8 17.2b 42.0b 30.5c
PGLa-I9 5.2b 30.0b 25.5c
PGLa-A10 15.0b 30.3b 29.2c
PGLa-G11 37.0b 52.1b 1.0c
PGLa-I13 26.4b 20.1b 32.7c
PGLa-A14 26.6b 21.5b 18.6c
PGLa-V16d 24.6 30.6 29.7
PGLa-A17d 14.0 25.5 33.6
PGLa-A20d 28.3 27.3 27.0
a Splittings from MLV samples multiplied by 2 for a direct comparison with oriented
samples.
b Data from [5].
c Data from [12].
d New data.
Fig. 3. PGLa was labeled with Ala-d3 at 11 different positions, one at a time. Here, the labeled positions and the corresponding 2H NMR spectra of PGLa in DMPC at a peptide-to-lipid
molar ratio P/L=1:50 are shown. The quadrupolar splittings obtained from these spectra are used to calculate the orientation of the peptide in the membrane.
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unnatural amino acids, which could potentially perturb the local
peptide conformation, even though no inﬂuence on biological activity
or CD line shape had been seen. Therefore, 2H NMR was used to
conﬁrm the surprising results from 19F NMR using Ala-d3 as a non-
disturbing isotope label. With this label, 11 positions (of which 6 are
native Ala in the PGLa sequence) along the entire α-helical stretch
between positions 6 and 20 have been labeled, giving the most
extensive SSNMR data set to date, and the detailed analysis of these
data is the subject of the next section.
4.3. Solid-state 2H NMR on PGLa and PGLa/magainin
PGLawas labeled with Ala-d3 at 11 positions (marked in Figs. 2 and
3), and 2H NMRexperiments of PGLa in DMPC at P/L=1:200 and 1:50
yielded the quadrupolar splittings listed in Table 2. The data from 8
positions have been previously published [5], and 2H NMR data for
positions Val-16, Ala-17, and Ala-20 are also included in Table 2. Fig. 3
shows the labeled positions on the PGLa molecule, together with the
corresponding 2H NMR spectra measured in oriented samples of
PGLa/DMPC at P/L=1:50. In these spectra, there is always a small
isotropic peak, originating from residual deuterium in the water, and
from peptides not bound to the membranes. Especially in MLVsamples, some of the peptides are moving freely in the water phase
and gives an isotropic signal [11].When a helical wave is ﬁtted to these
2H NMR data, the best-ﬁt orientation gives the tilt and rotation angle
Fig. 4. Data analysis of quadrupolar splittings measured by 2H NMR from Ala-d3 labeled PGLa in DMPC at P/L=1:200. (A) 2D rmsd plot as a function of the tilt (τ) and rotation (ρ)
angles used in the grid search, with the error in each point given in color coding. All 11 data points are used in this ﬁt. The best-ﬁt helix orientation corresponds to theminimum in the
plot, found at τ=95°, ρ=116°, and with Smol=0.75. (B) The quadrupolar splittings for the different labeled positions are plotted against the angle around the helical axis (see the
helical wheel in Fig. 2) to give a quadrupolar wave. The data are shown as ﬁlled squares, with the corresponding labeled position indicated. The quadrupolar wave obtained from the
best ﬁt to all 11 data points is shown. (C) 2D rmsd plot for which the data from positions Ala-17 and Ala-20 are excluded from the ﬁt. The best-ﬁt orientation is found at τ=99°,
ρ=114°, and Smol=0.71. (D) Quadrupolar wave for the best ﬁt, when the data from positions Ala-17 and Ala-20 are excluded. Filled squares show the data used in the ﬁt, while open
squares show the data that was not used.
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DMPC at 1:200. The 2D-plot in Fig. 4A shows the root mean square
deviation (rmsd) between the calculated and experimental splittings
for different values of τ and ρ, using all 11 data points. The well-
deﬁnedminimum is found to be located at τ=95° and ρ=116°. In the
ﬁtting process, an order parameter Smol, which represents the overall
peptide dynamics, is used as a free parameter (see above). In principle,
all three ﬁtting parameters could be represented in a three-
dimensional rmsd plot, but here only the τ and ρ angles are shown
for the best-ﬁt value of Smol=0.75. Fig. 4B shows the helical wave
corresponding to these best-ﬁt parameters, and the experimental data
is also plotted to be able to examine the quality of the ﬁt. It can be
noted that the ﬁt is not perfect, as some experimental data points
deviate considerably from the curve. However, if the data points from
positions Ala-17 and Ala-20 are excluded, the ﬁt is improved, as
demonstrated in Fig. 4C and D. This may indicate that the peptide does
not form a well-deﬁned α-helix all the way to the C-terminus.
Nevertheless, an ideal helix seems to be a good model for the central
part of the peptide, from positions 6 to 16. The best-ﬁt orientation of
this central stretch is found to be τ =99°, ρ=114°, Smol=0.71, and
the rmsd for this ﬁt is 2.4 kHz. When using only those 2H NMR data
points from the four non-perturbing positions, where Ala-d3 is placedin positions Ala-6, Ala-8, Ala-10, or Ala-14, almost the same
orientation is obtained, namely τ=98°, ρ=115°, Smol=0.66, and in
this case a better ﬁt is found with an rmsd of 1.3 kHz. A molecular
dynamics (MD) simulation using the 2H NMR data as constraints to
introduce orientation dependent pseudo-forces in the COSMOS-NMR
force ﬁeld also showed the peptide in an S-state [122].
The same analysis was performed for the 2H NMR data of PGLa in
DMPC at P/L=1:50, and the rmsd plot is shown in Fig. 5A and the
helical curve in Fig. 5B. In this case, all of the eleven data points ﬁt the
curve nicely, even at positions Ala-17 and Ala-20. The shape of the
curve is clearly different compared to P/L=1:200, and now the best-
ﬁt orientation is found to be τ =127°, ρ =111°, and Smol=0.77, with
an rmsd of 1.7 kHz. Only a very slight difference is seen when using
only the six non-perturbing Ala positions, giving τ =129°, ρ =107°,
Smol=0.73, and the rmsd is unchanged.
This distinct change of orientation from a surface-bound S-state to
a tilted T-statewith increasing peptide concentrationwas observed for
the ﬁrst time on PGLa and is illustrated in Fig. 6 (left part) [10]. Later,
the same kind of re-alignment was found the related AMP MSI-103
[59], where also S- and T-states with almost identical tilt angles as for
PGLa were seen, and for the cell-penetrating peptide MAP [123]. For
PGLa in oriented bilayers of DMPC, the threshold concentration for
Fig. 5. Data analysis of quadrupolar splittings measured by 2H NMR from Ala-d3 labeled PGLa in DMPC at P/L=1:50. See legend of Fig. 4. (A) Rmsd plot and (B) quadrupolar wave
obtained from the best ﬁt to all 11 data points. Here, the best-ﬁt orientation is found at τ =127° ρ =111°, Smol=0.77.
1675E. Strandberg et al. / Biochimica et Biophysica Acta 1788 (2009) 1667–1679reorientation is between 1:200 and 1:100 [11]. Oriented CD (OCD) of
PGLa, MSI-103 and MAP in DMPC was used to determine the accurate
threshold concentrations for the change from S- to T-state orientation
for these peptides. For PGLa the threshold concentration was found to
be P/L⁎=1:80, compared to 1:240 for MSI-103 and 1:160 for MAP
[124]. For PGLa this value reﬂects a slightly higher concentration than
estimated by NMR, but the discrepancy can be explained by differing
temperature and hydration of the samples in the NMR and OCD
experiments.
In another 2H NMR study of PGLa, where a wider range of lipid/
peptide systems were studied, it was seen that the S-state is not
changed when DMPC/DMPG (3:1) lipids are used instead of DMPC.
The T-state is also independent on lipid charge, and is stable for awide
range of peptide concentrations from 1:100 up to 1:20 [11]. We
therefore proposed that this stable state could be due to the formation
of peptide dimers, with a preferred helix-association angle leading to
the distinctive tilt angle. These dimers must have a symmetric
antiparallel alignment, since they only give one set of NMR splittings.
In the present study, using additional labeled positions, it is noted that
the α-helical part of the peptide extends further towards the C-
terminus at 1:50 than 1:200, which could be due to additional
stabilization from dimerization. The observed stabilization may also
be a consequence of the larger tilt angle as the C-terminal part of the
peptide moves deeper into the hydrophobic part of the membrane. If
the peptides form dimers, one may speculate whether the side chains
of the dimer interface might be distorted, and possibly the interface
residues could be identiﬁed from such distortions. However, the curve
in Fig. 5B shows no labeled positions with a strongly deviating
splitting, and there is no sign of such a packing interface. Especially ifFig. 6. Different alignment states of PGLa (light grey cylinder) in liquid crystalline
bilayers of DMPC/DMPG (3:1) in the presence and absence of its synergistic partner
MAG2 (dark grey cylinder), illustrated for low (1:200) and high (1:50) total peptide-to-
lipid ratios.the dimers would assemble via packing of the bulky hydrophobic side
chains of Ile-9 and Ile-13 (see helical wheel in Fig. 2), this packing is
likely to be disturbed bymutating these amino acids to Ala-d3, but this
is not observed. It therefore seems more likely that the dimers
assemble via an interface consisting of Ala or Gly residues, where a
replacement with an Ala-d3 has no or only a small inﬂuence on the
structure.
Under the conditions examined so far, PGLa was not found to
assume a transmembrane orientation in liquid crystalline bilayers,
which would be expected if it really forms pores through the
membrane, as proposed in several studies. It is possible that such
pores only form transiently and are not stable enough to be studied by
NMR, but that transient pores might still be lethal for a cell. Notably,
we have recently shown by 19F NMR that in gel-phase lipids PGLa is
fully inserted in a transmembrane I-state [125]. In these samples the
orientation changed to a T-state at higher temperature upon lipid acyl
chain melting, indicating that pores can be trapped at low tempera-
ture even when they are not stable at higher temperatures.
In previous ﬂuorescence studies, a 1:1 mixture of PGLa and MAG2
had been reported to have a higher rate of pore formation and a higher
pore stability than PGLa alone [75]. This system was studied by 2H
NMR, and indeed PGLa in the presence of MAG2 was observed in a
stable transmembrane I-state in liquid crystalline DMPC/DMPG (3:1)
bilayers at a low peptide concentration of P/L=1:100 for PGLa (or
1:50 for total peptide) [12]. In this study, PGLawas labeled with Ala-d3
at 8 different positions and mixed with unlabeled MAG2. From the 2H
quadrupolar splittings the best-ﬁt orientation of PGLa was a distinct I-
state with a helix tilt of 158°. The orientation of MAG2 was not
examined in this study. In the extended analysis presented here,
additional data are included from PGLa labeled with Ala-d3 at
positions Val-16, Ala-17 and Ala-20, for the same mixture of PGLa/
MAG2/DMPC/DMPG (1:1:75:25). The rmsd plot and helical curve for
this system is shown in Fig. 7. Fig. 7A and B shows the resulting
peptide alignment calculated from all 11 data points. As was the case
for PGLa/DMPC 1:50, the labeled positions Ala-17 and Ala-20 ﬁt well
with the rest, indicating a well-deﬁned helix all the way to the C-
terminus of the peptide. The quadrupolar wave corresponding to
τ=164° ﬁts most of the data, but two data points deviate strongly,
and lead to a very high rmsd of 6.7 kHz. When the two outliers, Gly-11
and Val-16, are excluded from the ﬁt, a much better ﬁt is found where
all the points lie on the curve almost perfectly, as shown in Fig. 7C and
D. In this case, the best-ﬁt orientation is τ =157°, ρ =97°,
Smol=0.83, and the rmsd is 1.5 kHz. It is not clear why Gly-11 and
Val-16 give splittings that do not ﬁt, but it might be that these
Fig. 7. Data analysis of quadrupolar splittings measured by 2H NMR from Ala-d3 labeled PGLa in PGLa/MAG2/DMPC/DMPC 1:1:75:25. See legend of Fig. 4. (A, B) Rmsd plot and
quadrupolar wave obtained using all 11 data points in the ﬁt. Here, the best-ﬁt orientation is found at τ=164°, ρ=95°, and Smol=1.00, but the rmsd is very high, 6.7 kHz. (C, D)
Rmsd plot and quadrupolar wave obtained when the data from positions Gly-11 and Val-16 are excluded from the ﬁt. The best-ﬁt orientation is found for τ=157°, ρ=97°,
Smol=0.83, and rmsd is reduced to 1.5 kHz. (E, F) Rmsd plot and quadrupolar wave obtained when only the six data points from non-disturbing Ala positions (Ala-6, Ala-8, Ala-10,
Ala-14, Ala-17, Ala-20) are used in the ﬁt. The best-ﬁt orientation is found at τ=159°, ρ=90°, Smol=0.86, and rmsd is in this case only 1.0 kHz.
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MAG2. However, since these two positions are on opposite faces of the
helix (see Fig. 2), probably only one of them is located in the
dimerization interface. Finally, if we include only the six non-
disturbing Ala positions in the ﬁt, almost the same result is obtained,with τ =159°, ρ =90°, Smol=0.86, and rmsd is improved to 1.0 kHz.
However, due to the smaller number of constraints the ρ angle is
slightly less well-deﬁned, as seen from the shape of the minimum in
the rmsd plot in Fig. 7E. The helical curve is shown in Fig. 7F, and
conﬁrms that the tilt angle of PGLa in this system is close to 160°.
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orientation and the effective length of the helix is sufﬁcient to span
the hydrophobic core of the membrane. The mobility, described by
Smol, is lower than for PGLa alone in the S- or T-state. Also, in the I-state
the peptide no longer rotates fast around the bilayer normal as it does
when MAG2 is not present [5,11,12]. Combined with the results of
previous studies, these ﬁndings indicate strongly that PGLa/MAG2
form heterodimers and that these assemble further to form a stable
transmembrane pore, as illustrated in Fig. 6 (right-hand part). This
system is the ﬁrst example where the pore structure of an AMP has
been directly observed in a liquid crystalline membrane. The known
synergistic effects between PGLa and MAG2 can thus be explained by
the formation of a stable pore from heterodimers. This assembly will
in turn lead to enhanced membrane permeabilization and can explain
the diverse biological effects described in Section 2 above.
5. Conclusions and perspectives
PGLa andMAG2 are two antimicrobial peptides found in the skin of
the frog X. laevis. Both have antibacterial, antifungal, antiviral and
anticancer activity, which all seem to be related to their ability to
permeabilize membranes and form transmembrane pores. A 1:1
mixture of these peptides has been shown to have strongly enhanced
synergistic effects, which have been attributed to the formation of
stable pores by heterodimers of PGLa and MAG2. Solid-state NMR is
the most suitable method to study the structures of these peptides in
membranes and has been successfully applied to give the orientation
in membranes of PGLa and MAG2 alone, and of PGLa in an equimolar
mixture of the two. A distinct re-alignment of PGLa from a surface-
bound state to a transmembrane I-state was induced by the presence
of MAG2 in a liquid crystalline DMPC/DMPG bilayer. The same SSNMR
approach has also been used to describe the behavior of other
membrane-active peptides, and is currently being applied to labeled
MAG2 in mixtures with PGLa, in order to further characterize the
PGLa/magainin complex.
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